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Immunoassays have been regarded as a possible alter-
native or supplement for measuring polycyclic aro-
matic hydrocarbons (PAHs) in the environment. Since 
there are too many potential cross-reactants for PAH 
immunoassays, it is difficult to determine all the cross-
reactivities (CRs) by experimental tests. In this study, 
the quantitative structure-activity relationship (QSAR) 
technique, comparative molecular field analysis 
(CoMFA), was applied to predict the CRs of a poly-
clonal antibody against pyrene. The CoMFA model 
developed shows that the CRs of the compounds are 
correlated to their 3D structure (n = 14, q2=0.527, 
r2=0.944, and Standard Error (SE) = 0.22478). The 
contributions of the steric and electrostatic fields to 
CRs are 95 and 5%, respectively. The results of the 
correlation predicted the CRs with actual CRs of ran-
domly selected test compounds and showed that the 
developed model has good prediction ability. The 
QSAR model has been applied to predict the CRs of 
other 17 PAHs. The 3D-QSAR model and its respec-
tive contour plot could be useful tools to further under-
stand the molecular nature of antibody-antigen interac-
tions. 
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polyclonal antibody against pyrene by comparative molecular field analysis 
Introduction 
 
Polycyclic aromatic hydrocarbons (PAHs) are a large 
group of organic compounds containing two or more 
fused aromatic rings constituted of carbon and hydro-
gen atoms. PAHs have received considerable attention 
because of their rich chemistry, physical properties, 
technological and industrial applications, aromaticity, 
and the role as a major class of environmental pollut-
ants and carcinogens (Schleyer 2001, Portella et al. 
2005, Poater et al. 2003, Wiberg 1997, Howard & Kry-
gowsk 1997, Suresh & Gadre 1999). PAHs rarely oc-
cur as individual compounds; they are usually found as 
a complex mixture of various compounds, which 
makes their analysis difficult. Conventional analytical 
methods for PAHs, such as gas chromatography (GC) 
and high-performance liquid chromatography (HPLC), 
are time-consuming and cumbersome (Poster et al. 
2006, Moret & Conte 2000, Boer & Law 2003). Im-
munochemical methods, such as enzyme-linked immu-
nosorbent assays (ELISAs) and immunosensors, are 
fast, selective, and inexpensive analytical methods that 
complement traditional chromatographic analytical 
procedures in the environmental analysis of PAHs 
(Kramer 1998, Barcelo et al. 1998, Fahnrich et al. 
2002, Szekacs et al. 1999, Li et al. 1999, Zhang et al. 
2006). 
An immunoassay is a very specific analytical 
method, but it is also known for its cross-reactivities 
(CRs), i.e., it responds to compounds structurally re-
lated to the analyte. CRs are expected not only in poly-
clonal immunoassays, but also in monoclonal ones. 
Although CR affects the specificity of the immunoas-
say and can result in biased test results, it can some-
times be used as a tool to identify metabolites or struc-
turally similar compounds as well as for class-specific 
immunoassays. 
The key step in developing an immunoassay for 
PAHs is the design and preparation of optimum hap-
tens for immunogens and competitors. The perform-
ance of the antibody within the assay is greatly af-
fected by the property of the hapten. Some haptens for 
PAHs have been reported (Spier et al. 2009, Fahnrich 
et al. 2002, Li et al. 1999), however, the antibody 
specificity resulting from the newly designed hapten is 
often unpredictable, and this knowledge comes only 
after time-consuming and laborious animal experi-
ments. As there are too many potential cross-reactants 
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and some of them may not be available for testing, it is 
not easy to determine all the CR values of the cross-
reactants for these immunoassays. It would thus be 
desirable to be able to predict the specificity of the an-
tibody obtained with a given hapten. As antigen-
antibody recognition is based on the steric criteria and 
the interactions resulting from the electronic properties 
of the molecules, molecular modeling may be helpful 
as it allows the determination of the volumes and 
charges of the compounds (Delaunay-Bertoncini et al. 
2003). 
 In this article, comparative molecular field 
analysis (CoMFA) was used to investigate the relation-
ship between the CRs and the structure of PAHs. The 
objective of this study is to determine the possibility of 
predicting the CRs of the PAHs in ELISAs by the 
quantitative structure-activity relationship (QSAR) 
method.  
 
Method 
 
CR data set 
17 molecules (Table 1) together with experimen-
tal CR data (Székács et al. 1999) were used to develop 
a model for predicting the CRs of a polyclonal anti-
body against pyrene. Pyrene was the reference sub-
stance during measurements. The training set con-
tained 14 molecules (No. 1-3, 5, 6, 8, 9, 11-17). The 
model was validated externally by excluding from the 
PLS analysis the three randomly selected test com-
pounds (No. 4, 7, and 10), representative of the train-
ing set. 
CR is normally quantified by comparing the as-
say’s response to a range of similar analytes (cross-
reactants) and expressed as a percentage. It is calcu-
lated accord- ing to Eq.1: 
 
CR(%) =           (1) 
 
Since activity data used for QSARs should be in 
molar dimensions, the molar CR (MCR) is defined in 
this article and used for QSAR analysis. It is 100 times 
the ratio between the molar IC50 value (mass IC50 value 
divided by the molecular weight) of the antigen and 
that of the 
c r o s s - re-
actant, as in-
dicated by Eq.2: 
 
MCR(%)=(2) 
 
CR was firstly converted to MCR, and then used 
for QSAR modeling and prediction. Finally, the pre-
dicted MCR obtained by the QSAR model was con-
verted to CR, and compared to the experimental CR 
value. 
 
CoMFA procedure 
The CoMFA procedures were performed with SYBYL 
X 2.0 (Tripos, St. Louis, MO, USA). The 3D structure 
of each compound was constructed and energy-
minimized to a low-energy conformation using the 
standard Tripos molecular force field. Atomic partial 
charges were computed using the Gasteiger-Hückel 
method. Most of the compounds studied in this work 
are flat geometrical compounds owing to their fused-
ring structure and planarity. The rigid character of 
these compounds reduced the number of conforma-
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Figure 1. The PAHs in the training set overlay on the tem-
plate molecule of pyrene. 
Figure 2. The PAHs in the training set were placed in a 3D 
cubic lattice. 
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No. Structure Compounds 
CR (%) 
MCR (%) 
Predicted Experimental 
1  Pyrene 37.0 100 100 
2  Pyrene-1-carboxaldehyde 19.3 25.1 28.58 
3  Benzo[a]pyrene 1.6 3.2 3.99 
4*  Benzoic[g,h,i]perylene 0.9 1.0 0.16 
5  Benzo[e]pyrene 1.8 0.9 1.12 
6  Phenanthrene 15.9 7.1 6.26 
7*  Chrysene 1.1 1.2 1.75 
8  Benzo[a]anthracene 0.6 0.2 0.23 
9  Dibenz (a,h) anthracene 0.1 0.2 0.28 
10*  Fluorene 1.1 1.5 0.44 
11  Naphthalene 0.2 0.2 0.13 
12  2,3-Diaminonaphthalene 0.2 0.2 0.16 
13  Fluoranthene 0.2 0.2 0.20 
14  Benzo[k]fluoranthene 0.1 0.2 0.25 
15  Benzo[a]fluoranthene 0.2 0.2 0.25 
16  Acenaphthene 2.5 2.3 1.75 
17  Acenaphthylene 0.4 0.6 0.44 
Table 1. Experimental and predicted CR data of PAHs in the training and the test sets 
*Randomly selected test compounds 
1
2
3
4
56
7
8
9
10
O
NH2
NH2
tional degrees of freedom, thus eliminating the need to 
select from numerous conformations for the alignment 
procedure. With the use of an atom-fit alignment 
scheme, the compounds were aligned to the template 
molecule of pyrene. 
Following alignment, the PAHs and related com-
pounds were placed in a 3D cubic lattice with 2-Å 
spacing. Steric (van der Waals) and electrostatic 
(Coulombic) field descriptors were calculated for each 
molecule at all lattice points using a probe represented 
by a sp3-hybridized carbon atom with +1.0 charges. 
We assumed that 0.2% was a low enough CR 
value to describe low levels of cross-reactions in this 
ELISA and considered the CR value “lower than 
0.2%” to be “ equal to 0.2%”. We then included these 
compounds in the data set subjected to CoMFA model-
ing. The log MCR data of 14 compounds were corre-
lated with the CoMFA-generated steric and electro-
static fields using the statistical method of partial least-
squares regression. 
 
Results and Discussion 
Figure 1 shows the results of the 14 PAHs in the 
training set aligned to the template molecule of pyrene 
and Figure 2 shows the PAHs in the training set placed 
in the 3D cubic lattice. A final CoMFA model in the 
training set, that included all the experimentally tested 
compounds with defined stereochemistry, was then 
generated. A tabulation of the actual and model pre-
dicted CRs for the final models is shown in Table 1. 
The result of the partial least-squares regression 
shows that the model requires four principal compo-
nents to explain the variance of logMCR. The non-
cross-validated square of the correlation coefficient (r2) 
is 0.91. The CoMFA model obtained was internally 
validated by leave-one-out cross-validation, and the 
cross validated square of the correlation coefficient 
(q2) was found to be 0.595. Since a QSAR model with 
a value of q2>0.5 is normally considered to possess 
significant predictive ability, this CoMFA model can 
be said to show fairly good predictive ability. As illus-
trated in Figure 3, a significant linear correlation was 
obtained between the corresponding CoMFA-predicted 
and experimental logarithmic CR values (r=0.9075, 
n=14, SE=0.310657). 
The basic principle of CoMFA is that if a group 
of similar compounds react on a receptor in the same 
way, their biological activities depend on the differ-
ence of the surrounding molecular field of each com-
pound. This molecular field can reflect the characteris-
tics of the nonbonding interactions between the mole-
cules and the receptors. Because the antigen-antibody 
interaction is such an interaction, using CoMFA to pre-
dict CR can be more accurate and successful, even 
though it needs more complex modeling steps. CoMFA 
also predicts the effects of structure changes on the CR 
of the molecule. 
Figure 4 depicts steric and electrostatic contour 
plots from the CoMFA analysis that show where 
changes in the steric and electrostatic fields are associ-
ated with CR. Greater CR values are correlated with 
more bulk near the green contours and with less bulk 
near the yellow contours (Figure 4a), whereas a more 
positive charge is correlated with the blue contours, 
and a more negative one with the red contours (Figure 
4b). 
As illustrated in Figure 4a, increasing the volume 
of position 9 of the pyrene ring would increase CR, 
and increasing the volume of position 6 and 10 would 
decrease CR. As illustrated in Figure 4b, a positive 
charge near the blue contour regions, at positions 3 to 
6, or a negative charge near the red contour regions, at 
positions 1 and 2, would favor increased CR. 
The contributions of the steric and electrostatic 
fields to CR, as indicated by the log MCR value, are 
95 and 5%, respectively. This shows that, in this 
ELISA, steric interactions between PAHs and the anti-
body play a more important role than electrostatic in-
teractions. 
The pyrene derivatives (No. 2-5), have the most 
common structure with the pyrene reference com-
pound, among the training set compounds (Table 1). 
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Figure 3. Plot of experimental versus predicted log CR val-
ues derived from the CoMFA model. 
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Figure 4. CoMFA contour plots of (a) steric field and (b) 
electrostatic field contributions of CR. 
As they have the negative charge close to the blue con-
tour regions, at positions 3 to 6, their CRs are de-
creased. Phenanthrene and its derivatives (No. 6-9), 
have a less common structure with the reference com-
pound. They have smaller CRs. Since compounds 8 
and 9 have the negative charge near the blue contour 
regions, at positions 3 to 6, their CRs are further de-
creased. Compound 10 (fluorine) has a similar struc-
ture to phenanthrene. Its CR is therefore similar to the 
latter. In addition, naphthalene and its derivatives (No. 
11-17) have a less common structure with the pyrene. 
As a result, they have smaller CRs. 
The ability of the model to properly predict the 
CRs of the molecules in the test set served as a meas-
ure of its robustness. The residual values correlating 
the predicted CRs with the actual CRs of the three ran-
domly selected test compounds (No. 4, 7, and 10 in 
Table 1) were -0.1, -0.1, and -0.4, respectively. These 
results show that the developed model has good pre-
diction ability. The model was subsequently applied to 
predict the CRs of other 17 molecules (Table 2) with-
out experimental activities. 
 
Conclusion 
 
PAHs have been designated as priority-pollutants and 
are regularly measured in polluted areas. In the envi-
ronment, single PAHs will not be detected. Instead, 
various PAHs and other related compounds will be 
found together with the target compound. Immunoas-
says often aid the environmental analysis of PAHs. CR 
is an important and useful property of such assays, and 
directly affects their specificity and selectivity, to-
gether with the results of the determination. In this ar-
ticle, the QSAR technology named CoMFA was used 
to predict the CRs of a polyclonal antibody against 
pyrene. The QSAR model demonstrated satisfactory 
predictive ability and exhibited a strong correlation 
between experimental and predicted CR values. 
CoMFA is developed on the basis of small molecule-
receptor interaction. It can provide an insight into the 
mechanisms of the antigen and antibody reactions in 
immunoassays. We believe that the established QSAR 
model could be employed for CR prediction and speci-
ficity evaluation for immunoassays, and it may also 
help in understanding the mechanisms of cross-
reaction and in the performance enhanced antibodies. 
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Compound Structure 
CR (%) 
Predicted 
1-Chloronaphthylene 
 
Cl
0.07 
2-Vinylnaphthalene 
 
0.11 
1-Methylnaphthalene 
 
0.09 
2-Methylnaphthalene 
 
0.10 
1-Phenylnaphthalene 
 
0.22 
2, 3, 5-Trimethylnaphthalene 
 
0.06 
1-Methylanthracene 
 
0.10 
9-Methylanthracene 
 
0.08 
2-Methylanthracene 
 
0.14 
2, 3-Dimethylanthracene 
 
0.09 
9, 10-Dimethylanthracene 
 
0.06 
Anthraquinone 
 O
O
0.08 
Benzo [b]fluoranthene 
 
0.12 
9-Fluorenone 
 
O
0.10 
Carbazole 
 
H
N
1.36 
Dibenzofuran 
 
O
0.15 
Dibenzothiophene 
 
S
0.09 
Table 2. The CRs predicted for other 17 molecules 
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